Back to Search Start Over

CYP3A4/5 Activity Probed with Testosterone and Midazolam: Correlation between Two Substrates at the Microsomal and Enzyme Levels

Authors :
Xiao, Kang
Gao, Jie
Weng, Shi-Jia
Fang, Yan
Gao, Na
Wen, Qiang
Jin, Han
Qiao, Hai-Ling
Source :
Molecular Pharmaceutics; 20240101, Issue: Preprints
Publication Year :
2024

Abstract

Testosterone (TST) and midazolam (MDZ) are widely used as probes to detect CYP3A4/5 activity, but the data acquired with these two substrates do not correlate well at the microsomal level (per milligram of microsomal protein), and the reason is unclear. In this study, CYP3A4/5 activity was probed with TST and MDZ at the microsomal and enzyme levels (per picomole of CYP3A4/5) in 72 human liver samples. Correlation coefficients were lower in Vmaxand CLintat the microsomal level, as compared with those at the enzyme level (Vmax0.658 vs 0.883; CLintno correlation vs 0.796). Compared with TST, MDZ was found to correlate better with the content of CYP3A4/5 (no correlation vs 0.431) and CYP3A5 (no correlation vs 0.447), and huge variations in enzyme content existed among different genotypes, which explained the lower degree of correlation at the microsomal level. In addition, different genotypes had varying effects on activity at the enzyme level, whereas the difference between activity at the enzyme level probed with TST and that probed with MDZ was not obvious (P> 0.05), indicating that the effect of gene polymorphisms on correlation between activity probed with these two substrates was limited at the enzyme level. In conclusion, our study demonstrates a high degree of correlation between CYP3A4/5 activity probed with TST and MDZ at the enzyme level but not at the microsomal level and allows us to correctly understand the influence of gene polymorphisms on the correlations.

Details

Language :
English
ISSN :
15438384 and 15438392
Issue :
Preprints
Database :
Supplemental Index
Journal :
Molecular Pharmaceutics
Publication Type :
Periodical
Accession number :
ejs47367630
Full Text :
https://doi.org/10.1021/acs.molpharmaceut.8b01043